Influence of Chemotherapy on Gamma-delta T Cells in Patients With Epithelial Ovarian Cancer

• Status: Withdrawn
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Female

Summary

In patients with an ovarian cancer, the treatment is currently based on surgery and chemotherapy.

The impact of chemotherapy on the expansion and functional abilities of Vgamma9Vdelta2 T cells has never been evaluated.

The long term goal is to give a rational to combine conventional treatment of ovarian cancer with immunotherapy based on Vgamma9Vdelta2 T cells.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rennes University Hospital
• Treatments: Carboplatin; Paclitaxel

Criteria

Inclusion Criteria:

• Patients with proven epithelial ovarian cancer

• Patients receiving carboplatin and / or taxol chemotherapy.

Exclusion Criteria:

• Minor patient

• Protected adult

• Lack of invasion to the final histological checking

• Absence of chemotherapy in the therapeutic plan of treatment